Infliximab-induced acne: Report of two cases [19]

British Journal of Dermatology

Volumn 156, Issue 2, 2007, Pages 402-403

  Bassi, E ^a   Poli, F ^a   Charachon, A ^a   Claudepierre, P ^a   Revuz, J ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AZATHIOPRINE; CORTICOSTEROID; DOXYCYCLINE; ETANERCEPT; INFLIXIMAB; LYMECYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RETINOID; TETRACYCLINE;

ACNE; ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; CASE REPORT; COMEDO; CROHN DISEASE; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; PAPULE; PRIORITY JOURNAL; PSORIASIS; PUSTULE; PUSTULOSIS PALMOPLANTARIS; SAPHO SYNDROME; SKIN NODULE; SUPPURATIVE HIDRADENITIS;

ACNE VULGARIS; ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DERMATOLOGIC AGENTS; GASTROINTESTINAL AGENTS; HUMANS; MALE; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846203357     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07665.x     Document Type: Letter

References (7)

1. Pandya K, Babar R. Severe nodulocystic acne vulgaris in a patient on infliximab (64th Annual Meeting of the American Academy of Dermatology, San Francisco, CA, U.S.A., 3-7 March 2006). J Am Acad Dermatol 2006; 54 (Suppl. 2):P126.
2. Krathen RA, Berthelot CN, Hsu S. Sustained efficacy and safety of infliximab in psoriasis: a retrospective study of 73 patients. J Drugs Dermatol 2006; 5:251-4.
3. Campione E, Mazzotta AM, Bianchi L, Chimenti S. Severe acne successfully treated with etanercept. Acta Derm Venereol 2006; 86:256-7.
4. Iqbal M, Kolodney MS. Acne fulminans with synovitis-acne-pustulosis- hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 2005; 52:S118-20.
5. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol 2006; 154:726-9.
6. Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-α may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestation. Rheumatology 2006; 45:730-3.
7. Thielen AM, Kuenzli S, Saurat JH. Cutaneous adverse events of biological therapy for psoriasis: review of the literature. Dermatology 2005; 211:209-17.